A new frontier in rapid, quantitative brain MRI.
Approximately ⅓ of COVID-19 patients have shown neurological symptoms like headache, an altered mental state, acute cerebrovascular disease, and epilepsy.
STAGE can be used to detect vascular damage and hemorrhagic lesions in the brain with greater detail than standard methods…
The STAGE protocol is designed to be highly sensitive to the visualization of lesions that may originate from trauma. STAGE has the ability to demonstrate key vascular brain damage which may be missed by conventional or low resolution scans…
STAGE is designed to benefit imaging and replace standard GRE and SWI in the acute and follow-up setting due to its high sensitivity to blood product lesions in the brain in the form of cerebral microbleeds and thrombus as well as…
STAGE provides a method to visualize brain tissue and neurovascular changes and lesions in the aging brain and Dementia. Phase data is used to reconstruct the source properties…
The STAGE protocol can be used to visualize changes in the Neuromelanin and iron content of key dopaminergic structures such as the Pars Compacta located as part of the Substantia Nigra…
The STAGE protocol helps to provide brain images which help differentiate Multiple Sclerosis lesion properties. The susceptibility-based STAGE outputs help differentiate normal appearing white matter from those which may have become demyelinated…
STAGE helps to provide a robust collection of contrast outputs which can help further differentiate tumor tissue and the changes occurring in surrounding tissue…
STAGE has been utilized to image Sturge Weber in the same way that SWI can be used. In these patients, it is critical to differentiate regions of bleeding versus those that are calcified…
With 40% faster MRI acquisition and processing, STAGE creates immediate clinical value by increasing throughput and workflow efficiency for your organization*. Given the growing constraints of reimbursement, labor costs and space, STAGE creates an opportunity to see more patients every day while also enhancing the quality of care.
*STAGE has not been evaluated by the FDA and is intended for research purposes only.
SpinTech’s rapid image sequencing and processing reduces acquisition time for comprehensive brain imaging by 40%, increasing throughput and improving patient experiences.
40% increased neuro imaging throughput can drive over $500k in new annual revenue for the average MRI unit, and the increase in scan quality and outcomes has the potential to drive referrals for new cases.
STAGE software integrates and enables your existing equipment for enhanced speed and diagnoses, which eliminates high capital expenses for upgrading your magnet or MRI suite.
The system uses a black box approach to integrate with virtually any existing system and MRI manufacturer. After processing, STAGE automatically sends 15 data-rich, standardized outputs to your existing PACS or database along with a summary report.
STAGE is compatible with most manufacturers existing equipment, providing not only accurate, repeatable results, but also rich, standardized datasets ideal for developing AI and research.
Microbleeds,
O2 Saturation
Microbleeds, Vessel Shearing
SN Swallow Tail
FLAIR/SWI
Mismatch
Microbleeds
Contact us to schedule a demo and see how SpinTech can improve your organization’s clinical performance.